Login to Your Account

Australia beefs up biovigilance rules for biologics sponsors

By Tamra Sami
Staff Writer

Tuesday, October 17, 2017

PERTH, Australia – Australia's Therapeutic Goods Administration received mixed comments from industry on two related draft guidances for reporting adverse events for biologics and for adopting an EU guideline on good pharmacovigilance practices.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription